↓ Skip to main content

Glutamatergic medication in the treatment of obsessive compulsive disorder (OCD) and autism spectrum disorder (ASD) – study protocol for a randomised controlled trial

Overview of attention for article published in this source, March 2016
Altmetric Badge

Mentioned by

twitter
2 X users

Citations

dimensions_citation
25 Dimensions

Readers on

mendeley
197 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Glutamatergic medication in the treatment of obsessive compulsive disorder (OCD) and autism spectrum disorder (ASD) – study protocol for a randomised controlled trial
Published by
Springer Nature, March 2016
DOI 10.1186/s13063-016-1266-8
Pubmed ID
Authors

Alexander Häge, Tobias Banaschewski, Jan K. Buitelaar, Rick M. Dijkhuizen, Barbara Franke, David J. Lythgoe, Konstantin Mechler, Steven C. R. Williams, Ralf W. Dittmann, the TACTICS Consortium

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 197 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Argentina 1 <1%
Unknown 196 99%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 29 15%
Researcher 25 13%
Student > Ph. D. Student 24 12%
Student > Master 23 12%
Other 10 5%
Other 31 16%
Unknown 55 28%
Readers by discipline Count As %
Psychology 34 17%
Medicine and Dentistry 29 15%
Neuroscience 13 7%
Nursing and Health Professions 10 5%
Pharmacology, Toxicology and Pharmaceutical Science 8 4%
Other 31 16%
Unknown 72 37%